Pharmafile Logo
Pharmafocus logo
Advanced Search

Azilect

Showing 5 posts of 5 posts found.

Takeda image

Takeda trials Teva Parkinson’s drug in Japan

January 9, 2015
Sales and Marketing Azilect, CHMP, Copaxone, Parkinson's, Takeda, rasagiline

Takeda has begun late stage trials for Teva’s Parkinson’s disease drug Azilect in Japan, with the hopes of bringing the …

News
Teva image

Teva under investigation for marketing practices

February 12, 2014
Sales and Marketing Azilect, Copaxone, Teva, fines, generics

Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …

News

Lundbeck issues Lexapro patent warning

November 3, 2010
Sales and Marketing Azilect, Cipralex, Forest Laboratories, Lexapro, Lundbeck, Xenazine

Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …

News

Lundbeck delivers strong results and builds on pipeline

May 7, 2010
2010 financials, Azilect, Lundbeck

Denmark-based Lundbeck has seen a large jump in revenue for the first quarter thanks to steady growth from its lead …

News

Lundbeck and Teva launch Azilect in France

January 20, 2010
Sales and Marketing Azilect, France, Lundbeck, Teva

Lundbeck and Teva France have launched Azilect in France following the successful conclusion of pricing and reimbursement discussions with the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025